Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

“Unique trend” and “contradictory trend” in discrimination of primary synchronous lung cancer and metastatic lung cancer

Authors: Cheng Shen, Huan Xu, Lunxu Liu, Yubin Zhou, Dali Chen, Heng Du, Zhaojie Han, Guowei Che

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Distinguishing between multiple primary lung cancers and metastatic tumors is often difficult when the tumor histology is same. Since genomic instability is a common feature of cancer, we hypothesized that independently arising neoplasms in an individual patient would exhibit measurable genomic variation, enabling discrimination of tumor lineage and relatedness. The feasibility of analyzing genomic instability expression profiles to distinguish multiple primary lung cancers from metastatic tumors was evaluated.

Methods

This study enrolled 13 patients, with multiple primary lung cancers demonstrating with the histology, who underwent surgery between April 2003 and December 2012 at the Department of the Thoracic Surgery at West China Hospital in Sichuan province of China and 10 patients who were diagnosed as metastasis disease during the same period for comparison purposes. Genomic DNA from lung cancers from individual patients was analyzed by six microsatellites (D2S1363, D6S1056, D7S1824, D10S1239, D15S822, and D22S689) with PCR to identify discordant allelic variation. The experiments were approved by the West China Hospital Ethics committee (No.2013 (33)) and all patients agreed to participate in the study and signed an informed consent form.

Results

All of the 10 patients with distant metastasis showed a consistent consequence that we called “unique trend” between primary tumor and distant metastasis. The “trend” is representive in this study, which means that all alleles corresponding to six microsatellite markers were detected in DNA from primary tumors but were reduced or not observed in DNA from metastatic tumors. In the group of synchronous lung tumor with different histological types, the result showed a “contradictory trend”. Some alleles were detected in DNA from primary tumors but were reduced or not observed in DNA from metastatic tumors and other alleles corresponding to six microsatellite markers were detected in DNA from metastatic tumors but were reduced or not observed in DNA from primary tumors. In the third group (synchronous lung tumor with same histological types), 2 of 8 patients showed “unique trend” and the others showed “contradictory trend”.

Conclusions

With polymorphic microsatellite markers, the “unique trend” that represents metastasis cancers and the “contradictory trend” that represents primary multiple tumors are useful in the diagnosis between tumors found at the same time in the pulmonary even diagnosed with the histopathological evaluation from a single patient.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferguson MK, DeMeester TR, DesLauriers J, Little AG, Piraux M, Golomb H: Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985, 89: 378-385.PubMed Ferguson MK, DeMeester TR, DesLauriers J, Little AG, Piraux M, Golomb H: Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985, 89: 378-385.PubMed
2.
go back to reference Verhagen AF, van de Wal HJ, Cox AL, Lacquet LK: Surgical treatment of multiple primary lung cancers. Thorac Cardiovasc Surg. 1989, 37: 107-111. 10.1055/s-2007-1013919.CrossRefPubMed Verhagen AF, van de Wal HJ, Cox AL, Lacquet LK: Surgical treatment of multiple primary lung cancers. Thorac Cardiovasc Surg. 1989, 37: 107-111. 10.1055/s-2007-1013919.CrossRefPubMed
3.
go back to reference Lam S, MacAulay C, Palcic B: Detection and localization of early lung cancer by imaging techniques. Chest. 1993, 103: 12-14. 10.1378/chest.103.1.12.CrossRef Lam S, MacAulay C, Palcic B: Detection and localization of early lung cancer by imaging techniques. Chest. 1993, 103: 12-14. 10.1378/chest.103.1.12.CrossRef
4.
go back to reference Woolner LB, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, Pairolero PC, Piehler JM, Taylor WF: Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc. 1984, 59: 453-466. 10.1016/S0025-6196(12)60434-0.CrossRefPubMed Woolner LB, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, Pairolero PC, Piehler JM, Taylor WF: Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc. 1984, 59: 453-466. 10.1016/S0025-6196(12)60434-0.CrossRefPubMed
5.
go back to reference van Rens MT, Zanen P, Brutel de La Rivière A, Elbers HR, van Swieten HA, van Den Bosch JM: Survival in synchronous vs single lung cancer: upstaging better reflects prognosis. Chest. 2000, 118: 952-958. 10.1378/chest.118.4.952.CrossRefPubMed van Rens MT, Zanen P, Brutel de La Rivière A, Elbers HR, van Swieten HA, van Den Bosch JM: Survival in synchronous vs single lung cancer: upstaging better reflects prognosis. Chest. 2000, 118: 952-958. 10.1378/chest.118.4.952.CrossRefPubMed
6.
go back to reference Che GW, Zhou QH: Modern ideas on the surgery treatment for multiple cancers of lung. Nat Med J China. 2007, 87: 1653-1655. [in Chinese] Che GW, Zhou QH: Modern ideas on the surgery treatment for multiple cancers of lung. Nat Med J China. 2007, 87: 1653-1655. [in Chinese]
7.
go back to reference Osaki T, Yoneda K, Yamamoto T, Kimura T, Matuoka H, Sakai H, Ryoke K: Clinical investigation on pulmonary metastasis of head and neck carcinomas. Oncology. 2000, 59: 196-203. 10.1159/000012161.CrossRefPubMed Osaki T, Yoneda K, Yamamoto T, Kimura T, Matuoka H, Sakai H, Ryoke K: Clinical investigation on pulmonary metastasis of head and neck carcinomas. Oncology. 2000, 59: 196-203. 10.1159/000012161.CrossRefPubMed
8.
go back to reference Mercer RR, Lucas NC, Simmons AN, Zander DS, Tsongalis GJ, Funkhouser WK, Coleman WB: Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung. Exp Mol Pathol. 2009, 86: 1-9. 10.1016/j.yexmp.2008.11.003.CrossRefPubMed Mercer RR, Lucas NC, Simmons AN, Zander DS, Tsongalis GJ, Funkhouser WK, Coleman WB: Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung. Exp Mol Pathol. 2009, 86: 1-9. 10.1016/j.yexmp.2008.11.003.CrossRefPubMed
9.
go back to reference Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, De Gregorio L, Manenti G, Radice P, Minoletti F: Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 1995, 55: 135-140.PubMed Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, De Gregorio L, Manenti G, Radice P, Minoletti F: Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 1995, 55: 135-140.PubMed
10.
go back to reference Flynn MJ, Rassl D, El Shahira A, Higgins B, Barnard S: Metachronous and synchronous lung tumors: five malignant lung pathologies in 1 patient during 7 years. Ann Thorac Surg. 2004, 78: 2154-2155. 10.1016/S0003-4975(03)01514-5.CrossRefPubMed Flynn MJ, Rassl D, El Shahira A, Higgins B, Barnard S: Metachronous and synchronous lung tumors: five malignant lung pathologies in 1 patient during 7 years. Ann Thorac Surg. 2004, 78: 2154-2155. 10.1016/S0003-4975(03)01514-5.CrossRefPubMed
11.
go back to reference Shimizu S, Yatabe Y, Koshikawa T, Haruki N, Hatooka S, Shinoda M, Suyama M, Ogawa M, Hamajima N, Ueda R, Takahashi T, Mitsudomi T: High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res. 2000, 10: 3994-3999. Shimizu S, Yatabe Y, Koshikawa T, Haruki N, Hatooka S, Shinoda M, Suyama M, Ogawa M, Hamajima N, Ueda R, Takahashi T, Mitsudomi T: High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res. 2000, 10: 3994-3999.
12.
go back to reference Pommier RF, Vetto JT, Lee JT, Johnston KM: Synchronous non-small cell lung cancers. Am J Surg. 1996, 171: 521-524. 10.1016/S0002-9610(96)00019-0.CrossRefPubMed Pommier RF, Vetto JT, Lee JT, Johnston KM: Synchronous non-small cell lung cancers. Am J Surg. 1996, 171: 521-524. 10.1016/S0002-9610(96)00019-0.CrossRefPubMed
13.
go back to reference Mathisen DJ, Jensik RJ, Faber LP, Kittle CF: Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg. 1984, 88: 502-510.PubMed Mathisen DJ, Jensik RJ, Faber LP, Kittle CF: Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg. 1984, 88: 502-510.PubMed
14.
go back to reference Rosengart TK, Martini N, Ghosn P, Burt M: Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg. 1991, 52: 773-779. 10.1016/0003-4975(91)91209-E.CrossRefPubMed Rosengart TK, Martini N, Ghosn P, Burt M: Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg. 1991, 52: 773-779. 10.1016/0003-4975(91)91209-E.CrossRefPubMed
15.
go back to reference Coleman WB, Tsongalis GJ: Molecular mechanisms of human carcinogenesis. EXS. 2006, 96: 321-349.PubMed Coleman WB, Tsongalis GJ: Molecular mechanisms of human carcinogenesis. EXS. 2006, 96: 321-349.PubMed
16.
go back to reference Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.CrossRefPubMed Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.CrossRefPubMed
17.
go back to reference Rai R, Peng G, Li K, Lin SY: DNA damage response: the players, the network and the role in tumor suppression. Cancer Genomics Proteomics. 2007, 4: 99-106.PubMed Rai R, Peng G, Li K, Lin SY: DNA damage response: the players, the network and the role in tumor suppression. Cancer Genomics Proteomics. 2007, 4: 99-106.PubMed
18.
go back to reference Martini N, Melamed MR: Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975, 70: 606-612.PubMed Martini N, Melamed MR: Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975, 70: 606-612.PubMed
19.
go back to reference Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications. Cancer Res. 2003, 63: 1727-1730.PubMed Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH: A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications. Cancer Res. 2003, 63: 1727-1730.PubMed
20.
go back to reference Kawaguchi T, Matsumura A, Iuchi K, Ishikawa S, Maeda H, Fukai S, Komatsu H, Kawahara M: Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol. 2006, 36: 7-11. 10.1093/jjco/hyi208.CrossRefPubMed Kawaguchi T, Matsumura A, Iuchi K, Ishikawa S, Maeda H, Fukai S, Komatsu H, Kawahara M: Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol. 2006, 36: 7-11. 10.1093/jjco/hyi208.CrossRefPubMed
21.
go back to reference Haraguchi S, Koizumi K, Hioki M, Hisayoshi T, Hirata T, Shimizu K: Hereditary factors in multiple primary malignancies associated with lung cancer. Surg Today. 2007, 37: 375-378. 10.1007/s00595-006-3420-5.CrossRefPubMed Haraguchi S, Koizumi K, Hioki M, Hisayoshi T, Hirata T, Shimizu K: Hereditary factors in multiple primary malignancies associated with lung cancer. Surg Today. 2007, 37: 375-378. 10.1007/s00595-006-3420-5.CrossRefPubMed
22.
go back to reference Reichel MB, Ohgaki H, Petersen I, Kleihues P: p53 mutations in primary human lung tumors and their metastases. Mol Carcinog. 1994, 9: 105-109. 10.1002/mc.2940090208.CrossRefPubMed Reichel MB, Ohgaki H, Petersen I, Kleihues P: p53 mutations in primary human lung tumors and their metastases. Mol Carcinog. 1994, 9: 105-109. 10.1002/mc.2940090208.CrossRefPubMed
23.
go back to reference Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res. 1993, 53: 1676-1683.PubMed Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res. 1993, 53: 1676-1683.PubMed
24.
go back to reference Gasparotto D, Maestro R, Barzan L, Vukosavljevic T, Doglioni C, Sulfaro S, Piccinin S, Boiocchi M: Recurrences and second primary tumours in the head and neck region: differentiation by p53 mutation analysis. Ann Oncol. 1995, 6: 933-939.PubMed Gasparotto D, Maestro R, Barzan L, Vukosavljevic T, Doglioni C, Sulfaro S, Piccinin S, Boiocchi M: Recurrences and second primary tumours in the head and neck region: differentiation by p53 mutation analysis. Ann Oncol. 1995, 6: 933-939.PubMed
25.
go back to reference Froio E, D’Adda T, Fellegara G, Ampollini L, Carbognani P, Rindi G: Three different synchronous primary lung tumours: a case report with extensive genetic analysis and review of the literature. Lung Cancer. 2008, 59: 395-402. 10.1016/j.lungcan.2007.07.007.CrossRefPubMed Froio E, D’Adda T, Fellegara G, Ampollini L, Carbognani P, Rindi G: Three different synchronous primary lung tumours: a case report with extensive genetic analysis and review of the literature. Lung Cancer. 2008, 59: 395-402. 10.1016/j.lungcan.2007.07.007.CrossRefPubMed
26.
go back to reference Geurts TW, Nederlof PM, van den Brekel MW, van’t Veer LJ, de Jong D, Hart AA, van Zandwijk N, Klomp H, Balm AJ, van Velthuysen ML: Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?. Clin Cancer Res. 2005, 11: 6608-6614. 10.1158/1078-0432.CCR-05-0257.CrossRefPubMed Geurts TW, Nederlof PM, van den Brekel MW, van’t Veer LJ, de Jong D, Hart AA, van Zandwijk N, Klomp H, Balm AJ, van Velthuysen ML: Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?. Clin Cancer Res. 2005, 11: 6608-6614. 10.1158/1078-0432.CCR-05-0257.CrossRefPubMed
Metadata
Title
“Unique trend” and “contradictory trend” in discrimination of primary synchronous lung cancer and metastatic lung cancer
Authors
Cheng Shen
Huan Xu
Lunxu Liu
Yubin Zhou
Dali Chen
Heng Du
Zhaojie Han
Guowei Che
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-467

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine